Christopher C Mader

This inventor holds 10 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Exicure, Inc., Northwestern University, Exicure Operating Company. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher C Mader. Retrieved from https://idiyas.com/inventor/christopher-c-mader

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 7)

% Patents Active = 90.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 74(Granted Patents)

Location History:

Cambridge, MA (US) (2019 - 2024)
Mendham, NJ (US) (2020 - 2024)

Company Filing History:

Northwestern University

patents

2 out of 4

Exicure Operating Company

patents

where one patent can have more than one assignee

Years Active: 2019-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11957788 - Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications (2024-04-16),

2. 11883535 - Liposomal particles, methods of making same and uses thereof (2024-01-30),

3. 11123294 - Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications (2021-09-21),

4. 10894963 - Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use (2021-01-19),

5. 10837018 - Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use (2020-11-17),

6. 10792251 - Liposomal particles, methods of making same and uses thereof (2020-10-06),

7. 10760080 - Anti-TNF compounds (2020-09-01),

8. 10434064 - Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications (2019-10-08),

9. 10208310 - Anti-TNF compounds (2019-02-19),

10. 10182988 - Liposomal particles, methods of making same and uses thereof (2019-01-22),

Title: The Innovative Mind of Christopher C Mader

Introduction: Christopher C Mader is a renowned inventor based in Cambridge, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Christopher C Mader's latest patents include inventions in the fields of biotechnology, artificial intelligence, and renewable energy.

Career Highlights: With a career spanning over two decades, Christopher C Mader has established himself as a leading figure in the innovation landscape. His work has been instrumental in shaping the future of technology.

Collaborations: Throughout his career, Christopher C Mader has collaborated with top research institutions, universities, and companies to bring his inventions to life. His collaborative spirit has led to the development of cutting-edge technologies.

Conclusion: Christopher C Mader's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on the world of technology is truly remarkable.

Profile summary based on public USPTO records.